Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Harvard Business School
Novartis
Cipla
Express Scripts
Baxter
Mallinckrodt
US Department of Justice
Cerilliant

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021529

« Back to Dashboard
NDA 021529 describes NEXPLANON, which is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the NEXPLANON profile page.

The generic ingredient in NEXPLANON is etonogestrel. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.

Summary for NDA: 021529

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:3
Formulation / Manufacturing:see details

Pharmacology for NDA: 021529

Ingredient-typeProgesterone Congeners

Suppliers and Packaging for NDA: 021529

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION 021529 NDA Organon USA Inc. 0052-0272 0052-0272-01 1 BLISTER PACK in 1 CARTON (0052-0272-01) > 1 IMPLANT in 1 BLISTER PACK
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION 021529 NDA Organon USA Inc. 0052-0274 0052-0274-01 1 BLISTER PACK in 1 CARTON (0052-0274-01) > 1 IMPLANT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:IMPLANT;IMPLANTATIONStrength68MG/IMPLANT
Approval Date:Jul 17, 2006TE:RLD:No
Patent:► SubscribePatent Expiration:Jul 28, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;IMPLANTATIONStrength68MG/IMPLANT
Approval Date:May 31, 2011TE:RLD:Yes
Patent:► SubscribePatent Expiration:Sep 28, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Aug 28, 2026Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 021529

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
Organon Usa Inc
IMPLANON
etonogestrel
IMPLANT;IMPLANTATION021529-001Jul 17, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Medtronic
US Army
QuintilesIMS
Citi
US Department of Justice
UBS
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot